Testing effectiveness (Phase 2)Study completedNCT03095066
What this trial is testing
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
Who this might be right for
Neurobehavioral Disinhibition
Otsuka Pharmaceutical Development & Commercialization, Inc. 168